These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 8677442

  • 1. Ifosfamide in the treatment of soft tissue sarcomas.
    Connelly EF, Budd GT.
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):16-21. PubMed ID: 8677442
    [Abstract] [Full Text] [Related]

  • 2. Single-agent ifosfamide studies in sarcomas of soft tissue and bone: the M.D. Anderson experience.
    Benjamin RS, Legha SS, Patel SR, Nicaise C.
    Cancer Chemother Pharmacol; 1993 Jun; 31 Suppl 2():S174-9. PubMed ID: 8453693
    [Abstract] [Full Text] [Related]

  • 3. High-dose ifosfamide in the treatment of sarcomas of soft tissues and bone.
    Demetri GD.
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):22-6. PubMed ID: 8677444
    [Abstract] [Full Text] [Related]

  • 4. Ongoing clinical studies of ifosfamide for pediatric cancer in the United States.
    Pratt CB.
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):84-90. PubMed ID: 8677456
    [Abstract] [Full Text] [Related]

  • 5. Ifosfamide in non-small cell lung cancer.
    Johnson DH.
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):7-10. PubMed ID: 8677453
    [Abstract] [Full Text] [Related]

  • 6. Treatment of advanced soft tissue sarcomas with ifosfamide and doxorubicin combination chemotherapy.
    Barişta I, Tekuzman G, Yalçin S, Güllü I, Güler N, Ozişik Y, Kars A, Celik I, Türker A, Altundağ K, Zengin N, Uner A, Baltali E, Firat D.
    J Surg Oncol; 2000 Jan; 73(1):12-6. PubMed ID: 10649272
    [Abstract] [Full Text] [Related]

  • 7. Results of single-agent and combination chemotherapy for advanced soft tissue sarcomas. Implications for decision making in the clinic.
    Demetri GD, Elias AD.
    Hematol Oncol Clin North Am; 1995 Aug; 9(4):765-85. PubMed ID: 7490240
    [Abstract] [Full Text] [Related]

  • 8. Sequential dose-dense doxorubicin and ifosfamide for advanced soft tissue sarcomas: a Phase II trial by the Spanish Group for Research on Sarcomas (GEIS).
    Maurel J, Fra J, López-Pousa A, García del Muro X, Balañá C, Casado A, Martín J, Martínez-Trufero J, de las Peñas R, Buesa JM, Spanish Group for Research on Sarcomas (GEIS).
    Cancer; 2004 Apr 01; 100(7):1498-506. PubMed ID: 15042685
    [Abstract] [Full Text] [Related]

  • 9. High-dose ifosfamide in bone and soft tissue sarcomas: results of phase II and pilot studies--dose-response and schedule dependence.
    Patel SR, Vadhan-Raj S, Papadopolous N, Plager C, Burgess MA, Hays C, Benjamin RS.
    J Clin Oncol; 1997 Jun 01; 15(6):2378-84. PubMed ID: 9196153
    [Abstract] [Full Text] [Related]

  • 10. High-dose ifosfamide in the treatment of advanced soft tissue sarcomas.
    Tursz T.
    Semin Oncol; 1996 Jun 01; 23(3 Suppl 7):34-9. PubMed ID: 8711500
    [Abstract] [Full Text] [Related]

  • 11. Crossover randomized comparison of intravenous versus intravenous/oral mesna in soft tissue sarcoma treated with high-dose ifosfamide.
    Mace JR, Keohan ML, Bernardy H, Junge K, Niebch G, Romeis P, Thoma A, Wagner T, Mueller U, Demetri G, Baker LH.
    Clin Cancer Res; 2003 Dec 01; 9(16 Pt 1):5829-34. PubMed ID: 14676103
    [Abstract] [Full Text] [Related]

  • 12. The role of ifosfamide in the treatment of sarcomas.
    Dirix LY, Van Oosterom AT.
    Semin Oncol; 1989 Feb 01; 16(1 Suppl 3):39-45. PubMed ID: 2649984
    [Abstract] [Full Text] [Related]

  • 13. Phase I trial of a 24-h continuous infusion of ifosfamide/mesna in acute lymphoblastic leukemia.
    Otero JC, Solidoro A, Casanova L, Vallejos C, Rodriguez W.
    J Exp Ther Oncol; 1996 Mar 01; 1(2):84-7. PubMed ID: 9414391
    [Abstract] [Full Text] [Related]

  • 14. Safety and efficacy of adjuvant single-agent ifosfamide in uterine sarcoma.
    Kushner DM, Webster KD, Belinson JL, Rybicki LA, Kennedy AW, Markman M.
    Gynecol Oncol; 2000 Aug 01; 78(2):221-7. PubMed ID: 10926807
    [Abstract] [Full Text] [Related]

  • 15. Phase III trial of two investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study.
    Lorigan P, Verweij J, Papai Z, Rodenhuis S, Le Cesne A, Leahy MG, Radford JA, Van Glabbeke MM, Kirkpatrick A, Hogendoorn PC, Blay JY, European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study.
    J Clin Oncol; 2007 Jul 20; 25(21):3144-50. PubMed ID: 17634494
    [Abstract] [Full Text] [Related]

  • 16. Perspectives on anthracyclines plus ifosfamide in advanced soft tissue sarcomas.
    Casali P, Pastorino U, Azzarelli A, Bertulli R, Zucchinelli P, Devizzi L, Santoro A.
    Cancer Chemother Pharmacol; 1993 Jul 20; 31 Suppl 2():S228-32. PubMed ID: 8453704
    [Abstract] [Full Text] [Related]

  • 17. Current trials and new aspects in soft tissue sarcoma of adults.
    Issels RD, Schlemmer M.
    Cancer Chemother Pharmacol; 2002 May 20; 49 Suppl 1():S4-8. PubMed ID: 12042982
    [Abstract] [Full Text] [Related]

  • 18. Dose-intensive ifosfamide for the treatment of non-Hodgkin's lymphoma.
    Vose JM.
    Semin Oncol; 1996 Jun 20; 23(3 Suppl 6):33-7. PubMed ID: 8677446
    [Abstract] [Full Text] [Related]

  • 19. The role of ifosfamide in the treatment of adult soft tissue sarcomas, Ewing's sarcoma, and osteosarcoma: a review.
    Dirix LY, Van Oosterom AT.
    Semin Oncol; 1990 Apr 20; 17(2 Suppl 4):50-7. PubMed ID: 2185547
    [Abstract] [Full Text] [Related]

  • 20. New drugs for the treatment of sarcomas.
    van Oosterom AT, Verweij J.
    Hematol Oncol Clin North Am; 1995 Aug 20; 9(4):909-25. PubMed ID: 7490248
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.